SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-20-005790
Filing Date
2020-03-09
Accepted
2020-03-09 17:17:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDED SCHEDULE 13G ea119458-13ga4ubs_protalix.htm SC 13G/A 40666
  Complete submission text file 0001213900-20-005790.txt   42385
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 20698879
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE NORTH WACKER DRIVE 31ST FLOOR CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE 31ST FLOOR CHICAGO IL 60606 3125256000
UBS OCONNOR LLC (Filed by) CIK: 0001132716 (see all company filings)

IRS No.: 061569842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A